NCT00240084View on ClinicalTrials.gov

Nesiritide and Vo2 Max in Heart Failure Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Heart Failure
Interventions
DRUG

nesiritide (Natrecor(TM))

administration of IV nesiritide

Trial Locations (1)

14642

University of Rochester Medical Center, Rochester

All Listed Sponsors
collaborator

Scios, Inc.

INDUSTRY

lead

University of Rochester

OTHER

NCT00240084 - Nesiritide and Vo2 Max in Heart Failure Patients | Biotech Hunter | Biotech Hunter